Katrina AdamsChairman of the Board and President, United States Tennis Association
Katrina Adams is the Chairman of the Board and President of the United States Tennis Association, a position she assumed in January 2015. She also serves as Chairman of the US Open.
Adams is the first African-American, first former professional tennis player and youngest person to serve as President in the association's 137-year history. She is currently serving a second two-year term, which also marks the first time in the history of the USTA that an individual has served a second two-year term. Adams also served as CEO from 2015-2017.
In the current term, Adams serves on the USTA's Budget Committee, International Committee, Executive Committee and Compensation Committee. She also serves on the board of directors of the USTA Foundation, the International Tennis Hall of Fame, and the Ross Initiative for Sports and Equality (RISE). In addition, Adams also is a member of the Grand Slam Board and an active member of the ADL Sports Leadership Council.
In 2015, Adams was elected Vice President of the International Tennis Federation. And in 2016, she was appointed as Chairman of the Fed Cup Committee, which governs Fed Cup, the largest annual international team competition in women's sports. In 2018, Adams was named Chairman of the Women in Sports Committee.
An accomplished professional player, Adams competed for 12 years on the WTA Tour. She ranked as high as No. 67 in the world in singles and No. 8 in doubles, winning 20 career doubles titles and reaching the quarterfinals or better in doubles at all four Grand Slam events. Her best Grand Slam singles result was reaching the fourth round at Wimbledon in 1988.
While an active pro, Adams served on the board of directors of the WTA Tour as a player representative for four one-year terms, and on the WTA's Players Association for five two-year terms. After leaving the tour, Adams was a USTA National Tennis Coach from 1999-2002. She joined the USTA's board of directors in 2005, serving as a Director at Large and as the association's Vice President and First Vice President before assuming the presidency.
Adams attended and played her collegiate tennis at Northwestern University, majoring in communications and helping the Wildcats to a Big Ten championship in 1986. That year, she was named the Intercollegiate Tennis Association (ITA) Rookie of the Year. In 1986 and 1987, Adams was named NCAA All-American. Also in 1987, she became the first African-American to win an NCAA doubles title. In 1998 Adams was inducted into the Northwestern Hall of Fame.
Among her many accolades, Adams is a three-time WTA Player Service Award recipient and received the WTA Althea Gibson Award in 2003. In addition, she was named to the USTA Midwest Section Hall of Fame in 2005, the Chicago District Tennis Hall of Fame in 2008, the Black Tennis Hall of Fame in 2012, the ITA Women's Tennis Hall of Fame in 2014, and the USTA Eastern Section Tennis Hall of Fame in 2015. Also in 2015, she was named one of the "25 Influential Black Women in Business," by The Network Journal and as one of Sports Business Daily's "Game Changers." Adams was inducted into the 2016 class of the Boys and Girls Clubs of America Alumni Hall of Fame, becoming the first individual from the sport of tennis to be inducted. She's been named to Adweek magazine's "Most Powerful Women in Sports" list in 2016 and 2017, and Forbes magazine's "Most Powerful Women in Sports" list in 2017. Also in 2017, Adams was named to Ebony magazine's "Power 100" list.
In addition to her duties with the USTA, Adams is a contributor on CBS Sports Network's first all-female sports show, "We Need to Talk." She also serves as a television analyst for Tennis Channel and as a contributor to Tennis magazine and tennis.com, providing instructional articles and videos.
Since 2005 Adams also has served as the Executive Director of the Harlem Junior Tennis and Education Program, a National Junior Tennis & Learning network (NJTL) chapter based in New York City.
A Chicago native, Adams currently lives in White Plains, N.Y.
Katrina AdamsChairman of the Board and President, United States Tennis AssociationBio
Catherine "CiCi" BellisProfessional Tennis Player
CiCi Bellis has won one singles title on the WTA tour and six singles and two doubles titles on the ITF tour in her career. On August 14, 2017, she reached her best singles ranking of world no. 35. On July 17, 2017, she peaked at world number 161 in the doubles rankings. Bellis was ranked the no. 1 junior tennis player in the world in September 2014, and was declared 2014 ITF Junior World Champion.
Catherine "CiCi" BellisProfessional Tennis PlayerBio
Elizabeth Blackburn, PhD, AC, FRS, FAA, FRSNPresident, The Salk Institute
Dr. Elizabeth Blackburn won the Nobel Prize in Physiology or Medicine in 2009 for discovering the molecular nature of telomeres, the ends of chromosomes that serve as protective caps essential for preserving genetic information, and for co-discovering telomerase, an enzyme that maintains telomere ends. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer, and her work helped launch entire new fields of research in these areas.
Elizabeth Blackburn, PhD, AC, FRS, FAA, FRSNPresident, The Salk InstituteBio
Marc J. BlazerChairman and CEO of Overture Holdings
Marc Blazer is the Chairman and CEO of Overture Holdings, an investment firm with interests in hospitality and consumer businesses.
He is Chairman of the Board of Noma Holdings, the parent company of world renowned restaurant noma; co-founder and Director of Ahimsa Partners, a venture that licenses, owns, and operates hospitality businesses in India; was a co-founder of BMB Hospitality BV, a Netherlands based company that is the owner of restaurants in Vietnam; and co-founder and Executive Chairman of PRIOR, a private membership travel company.
From November 2009 until January 2010, Marc was the CEO of Protagoras Capital, and a managing director of its parent BTIG, an institutional trading firm. From August 2007 until January 2010, Marc was President of Overture Acquisition Corp., a NYSE/Amex listed consumer brand investment vehicle.
From November 2000 to August 2007, Marc was a partner and the global head of investment banking at Cantor Fitzgerald. While at Cantor Fitzgerald, he served on the advisory board of Enertech Capital III, a venture capital fund from March 2006 to July 2007. He was named one of Investment Dealer’s Digests 40-under-40 in 2006. Prior to joining Cantor Fitzgerald, Mr. Blazer spent six years at ChaseMellon Financial Corp. (now Bank of New York Mellon), a joint-venture between Chase Manhattan Corporation and Mellon Financial Group LLC from 1994 to 2000.
Earlier in his career, Marc was an advisor to members of Congress in both the US House of Representatives and Senate on tax matters, banking and securities legislation, international trade policy, and foreign relations.
Marc earned a graduate degree from the London School of Economics in 1992, and a BA from the University of Maryland in 1990. Mr. Blazer is Chairman of the Board of the MAD Foundation, a non-profit focused on “Making a Better World Through a Better Meal,” and a member of the Advisory Board of Kopernik, a US non-profit organization focused on marrying life-enhancing technologies with under served communities in developing countries. Marc is married to Esther Wahrhaftig, and has two children.
Marc J. BlazerChairman and CEO of Overture HoldingsBio
Mark BritnellChairman & Partner, Global Health Practice at KPMG
Dr. Mark Britnell is Chairman and Partner of the Global Health Practice at KPMG. Since 2009, he has worked in 60 countries, helping governments, public and private sector organizations with operations, strategy and policy. He has a pioneering and inspiring global vision for healthcare in both the developed and developing world and has written extensively on what works around the world. As Chairman for the Global Healthcare Practice, Mark has responsibility for KPMG’s 4,000 health staff across more than 40 countries. Mark has dedicated his professional life to healthcare and has led organizations at local, regional, national and global levels.
Mark BritnellChairman & Partner, Global Health Practice at KPMGBio
David Calabrese, RPh, MHPSenior Vice President and Chief Pharmacy Officer, OptumRx
David Calabrese currently serves as senior vice president, chief pharmacy officer (CPO) for OptumRx. In this capacity, his primary responsibilities include executive level oversight and strategic accountability for several of the organization’s clinical programs and services, including Clinical Account Management, Pharmacy and Therapeutics (P&T) Committee functions and Clinical Quality Management. Prior to his current position, he served as the CPO of Catamaran, one of the nation’s largest pharmacy benefit management (PBM) companies serving 35 million lives, which combined with OptumRx in 2015. Before joining Catamaran, David served as chief clinical officer at MedMetrics Health Partners, a small regionally-based PBM, held managed care clinical pharmacy leadership roles at Harvard Pilgrim Health Care and with CareGroup, an integrated health care system.
David Calabrese, RPh, MHPSenior Vice President and Chief Pharmacy Officer, OptumRxBio
Robert M. Califf, MD, MACCVice Chancellor for Health Data Science and Director of the Center for Integrated Health Data Science at Duke Health; the Donald F. Fortin, MD Professor of Cardiology, Duke University School of Medicine; Commissioner U.S. Food & Drug Administration (2016-2017)
Robert M. Califf, MD, MACC, is vice chancellor for health data science and director of the Center for Integrated Health Data Science at Duke Health, the Donald F. Fortin, MD Professor of Cardiology in the Duke University School of Medicine, and an advisor for Verily Life Sciences, a member of the Alphabet family of companies formed by Google. He served in the administration of President Barack Obama as Deputy Commissioner for Medical Products and Tobacco in the U.S. Food and Drug Administration (FDA) from 2015-106, and as Commissioner of Food and Drugs from 2016-2017.
Robert M. Califf, MD, MACCVice Chancellor for Health Data Science and Director of the Center for Integrated Health Data Science at Duke Health; the Donald F. Fortin, MD Professor of Cardiology, Duke University School of Medicine; Commissioner U.S. Food & Drug Administration (2016-2017)Bio
Richard Carmona, MD, MPH, FACS17th Surgeon General of the United States; Chief of Health Innovations, Canyon Ranch; Distinguished Professor, University of Arizona; Chairman, National Advisory Board, Lake Nona Impact Forum
Richard Carmona was the 17th Surgeon General of the United States. He is currently Chief of Health Innovations at Canyon Ranch and Distinguished Professor at both the University of Arizona and Ohio State University. He serves on several corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.
Richard Carmona, MD, MPH, FACS17th Surgeon General of the United States; Chief of Health Innovations, Canyon Ranch; Distinguished Professor, University of Arizona; Chairman, National Advisory Board, Lake Nona Impact ForumBio
Gloria CaulfieldExecutive Director, Lake Nona Institute
Gloria Caulfield leads health and wellness strategy and planning for the Lake Nona Institute. Passionate about innovating pivotal health and wellness solutions, Gloria manages corporate partnerships in the Lake Nona community to advance research, technology and new solutions for improved quality of life.
Prior to joining Lake Nona Institute, Gloria worked as an executive for a national consulting group with the mission of identifying and quantifying new revenue streams for large health care systems across the country. In addition, she served as the Executive Director for Community Development at Florida Hospital, directing strategic community health initiatives and employee relations in Central Florida.
Gloria is on the Executive Leadership Council for the American Heart Association, co-chaired the philanthropy committee for Hospice of the Comforter, and is a member of the University of Central Florida’s Town & Gown Council, actively increasing awareness of critical health issues.
Gloria has a BA in Business Administration and is a member of the American College of Healthcare Executives as well as the Society for Healthcare Strategy and Market Development.
Gloria CaulfieldExecutive Director, Lake Nona InstituteBio
Deepak Chopra, MD, FACPFounder, The Chopra Foundation and Co-Founder, The Chopra Center for Wellbeing
Deepak Chopra, founder of The Chopra Foundation and co-founder of The Chopra Center for Wellbeing is a world-renowned pioneer in integrative medicine and personal transformation, and is Board Certified in Internal Medicine, Endocrinology and Metabolism. He is a Fellow of the American College of Physicians, a member of the American Association of Clinical Endocrinologists and Clinical Professor in the Department of Family Medicine and Public Health at the University of California, San Diego, Health Sciences. TIME magazine has described him as "one of the top 100 heroes and icons of the century.”
Deepak Chopra, MD, FACPFounder, The Chopra Foundation and Co-Founder, The Chopra Center for WellbeingBio
Sandy ClimanPresident, Entertainment Media Ventures, Inc.
Founded in 1999 by Mr. Climan, EMV is active in media investment and strategic advisory work, with a particular focus on innovative technologies and entities currently impacting the traditional boundaries of business, media and entertainment. He is an investor, producer and considered a media visionary.
Mr. Climan also serves as CEO of Oz Media, LLC. In 2013, Mr. Climan partnered with Dr. Mehmet Oz to form Oz Media, which is dedicated to building companies committed to improving health and wellness across cultures and geographies. Throughout his career, Mr. Climan has held senior management positions in the media and entertainment industry. Mr. Climan served as the first CEO of 3ality Digital and served as the founding head of CAA’s corporate practice. Additionally, while at CAA, Mr. Climan was part of the senior management team for 12 years, representing talent including Robert De Niro, Robert Redford, Kevin Costner, Danny DeVito, and Michael Mann.
Earlier positions included President of Worldwide Business Development of Universal Studios, President of Lion’s Gate Studios, President of Wescom Productions and executive positions in motion picture production, distribution, and pay-television at MGM.
Notable achievements include: Executive Producer of the first digital live-action 3D motion picture, “U2 3D” and Producer of “The Aviator.”
Mr. Climan serves on several charitable boards, including The American Cinematheque, The Fulfillment Fund, and the UCLA School of Theater, Film and Television. From 2008-2012, Mr. Climan served as a member of the Advisory Committee to the Director of the Centers for Disease Control and Prevention. Mr. Climan also serves as an advisor on entertainment and media to the World Economic Forum.
Sandy ClimanPresident, Entertainment Media Ventures, Inc.Bio
Christopher Coburn, MBAChief Innovation Officer, Partners HealthCare System & President of Partners HealthCare International
Chris Coburn is Chief Innovation Officer, Partners HealthCare System and President of Partners HealthCare International. Partners is the largest academic research enterprise in the United States with $12 billion in revenue, more than 1.5 million patients and over $1.6 billion in annual research expenditures. Mr. Coburn leads a team of more than 110 tasked with the worldwide commercial application of the unique capabilities and discoveries of Partners’ faculty and its 73,000 employees. Prior to joining Partners, Mr. Coburn was the founding director of Cleveland Clinic Innovations and served for 13 years as its executive leader.
Christopher Coburn, MBAChief Innovation Officer, Partners HealthCare System & President of Partners HealthCare InternationalBio
Craig CogutChairman and President, Pegasus Capital
Mr. Cogut has spent a career building successful investment businesses. He founded Pegasus Capital Advisors in 1996 and serves as its Chairman and President. Through Mr. Cogut’s leadership, Pegasus has focused increasingly on areas influenced by global resource scarcity and the need for resource efficiency, as well as on the growth in demands for human wellness. In 1990, Mr. Cogut co-founded and was one of the original partners at Apollo Advisors L.P., a position he held for five years preceding the creation of Pegasus.
An active philanthropist in the fields of improving education, building civil society and championing environmental and health issues, Mr. Cogut helped establish The Cogut Center for the Humanities at Brown University where he also served as trustee for several terms. In 2011, Mr. Cogut co-founded The Polyphony Foundation, an organization created to provide equal opportunity music education for Arab and Jewish Israeli youth, where he currently serves as its Chairman. In addition, he serves as a board member for The McCain Institute for International Leadership at Arizona State University, for the R-20 Regions of Climate Action, for Six Senses (a luxury hotel and resort chain focused on sustainability and wellness), for Lighting Science Group (an LED company focused on using science to improve the health of humans on the planet), for PanTheryx (a medical nutrition company whose primary product, DiaResQ, was chosen by The Innovation Countdown 2030 as one of the top 30 lifesaving innovations with great promise to transform global health by 2030) and as a board member emeritus for the Arizona State University’s Global Institute of Sustainability. Mr. Cogut is an alumnus of Brown University and Harvard Law School.
Craig CogutChairman and President, Pegasus CapitalBio
Toby Cosgrove, MDCEO & President, Cleveland Clinic
Toby Cosgrove is CEO and President of Cleveland Clinic. He heads an $8 billion healthcare system including a main campus, 10 regional hospitals, 18 family health and surgery centers, and hospitals and clinics in Florida, Nevada, Toronto, Abu Dhabi and London (opening 2020). Under his leadership, Cleveland Clinic has become the No. 2 ranked hospital in America (U.S. News & World Report). He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.
Toby Cosgrove, MDCEO & President, Cleveland ClinicBio
Susan DentzerPresident and Chief Executive Officer, The Network for Excellence in Health Innovation
Susan Dentzer is the President and Chief Executive Officer of the NEHI, the Network for Excellence in Health Innovation, a nonprofit, nonpartisan organization composed of more than 100 stakeholder organizations from across all key sectors of health and health care. NEHI's mission is to advance innovations that improve health, enhance the quality of health care, and achieve greater value for the money spent. With offices in Washington, DC, and Boston, Massachusetts, NEHI conducts independent, objective research and thought leadership to accelerate these innovations and bring about changes within health care and public policy.
One of the nation's most respected health and health policy thought leaders and journalists, and a frequent speaker and commentator on television and radio, including NPR, Dentzer previously served as senior policy adviser to the Robert Wood Johnson Foundation. Prior to that, she was editor-in-chief of the journal Health Affairs, and from 1998 to 2008, she served as the on-air Health Correspondent for the PBS NewsHour.
Dentzer is an elected member of the National Academy of Medicine and the Council on Foreign Relations. She is a member of the Board of Directors of the International Rescue Committee, a leading humanitarian organization; a member of the board of directors of Research!America, which works to advance research to improve health; and a member of the board of directors of the Public Health Institute. She is a fellow of the National Academy of Social Insurance and the Hasting Center, an institution dedicated to bioethics and the public interest. She previously served as a public member of the American Board of Medical Specialties.
A graduate of Dartmouth, Dentzer formerly chaired the Dartmouth Board of Trustees, and is a member of the Board of Overseers of Dartmouth Medical School. She and her husband, Charles Alston, have three grown children, and live in Chevy Chase, MD.
Susan DentzerPresident and Chief Executive Officer, The Network for Excellence in Health InnovationBio
Deborah DiSanzoGeneral Manager, IBM Watson Health
Deborah DiSanzo is the global General Manager for IBM Watson Health, the business unit founded to achieve IBMs next ‘moonshot’: to advance health at a global scale. Deborah leads a team of almost 7,000 employees around the world, ranging from medical experts to health economists to data scientists, UX experts and developers. Under her leadership, Watson Health has secured relationships with top collaborators, partners and clients across healthcare and life sciences. Deborah has a distinguished career working at the intersection of healthcare and technology. Prior to joining IBM, she was CEO of Philips Healthcare. Previously, she held management roles at Hewlett-Packard and Apollo Computer.
Deborah DiSanzoGeneral Manager, IBM Watson HealthBio
Daniel DoctoroffChairman & CEO, Sidewalk Labs
Daniel L. Doctoroff is CEO of Sidewalk Labs, an urban innovation company he launched with Google to improve cities for residents, businesses and city governments. Prior to founding Sidewalk, he was president and CEO of Bloomberg L.P. Dan previously served as deputy mayor for economic development and rebuilding for the City of New York. With Mayor Michael R. Bloomberg, Dan led the city’s dramatic economic resurgence, spearheading the effort to reverse New York’s fiscal crisis after 9/11 through a five-borough economic development strategy, including the creation of PlaNYC.
Daniel DoctoroffChairman & CEO, Sidewalk LabsBio
Dr. P. Murali Doraiswamy, MBBS, FRCP, FANAProfessor of Psychiatry and Geriatrics; Senior Fellow, Center for the Study of Aging, Duke University
Dr. Doraiswamy is a doctor and brain scientist at Duke University Health System where he directs a leading clinical trials unit focused on Alzheimer’s disease prevention. He also serves as an advisor to many government agencies, advocacy groups and businesses, and is a member of the World Economic Forum’s Future Councils. He is the brain health advisor for Men’s Health magazine and AARP Magazine, and is the co-author of a popular book, The Alzheimer’s Action Plan.
Dr. P. Murali Doraiswamy, MBBS, FRCP, FANAProfessor of Psychiatry and Geriatrics; Senior Fellow, Center for the Study of Aging, Duke UniversityBio
A.J. DrexlerCEO & Chief Strategist, Campos Inc.
A.J. Drexler is the CEO and Chief Strategist at Campos Inc, a market research and strategic planning firm that uses deep consumer insights to construct customer experiences and drive strategy.
A.J. DrexlerCEO & Chief Strategist, Campos Inc.Bio
Andrew C. von Eschenbach, MDPresident, Samaritan Health Initiatives: Adjunct Professor at University of Texas MD Anderson Cancer Center; Commissioner U.S. Food & Drug Administration (2005-2009)
Andrew C. von Eschenbach, M.D. currently serves as President of Samaritan Health Initiatives, Inc. and as an Adjunct Professor at University of Texas MD Anderson Cancer Center. From September of 2005 to January 2009 he served as Commissioner of Food and Drugs where he championed an agenda to modernize the FDA by process improvement of the regulatory pathway for drugs and medical devices and by fostering creative projects, including FDA’s Critical Path Initiative (designed to bring modern tools of science to the product development process); work plans like the FDA’s Food Protection Plan; and most especially the nurturing of the workforce through initiatives, such as an Agency-wide fellowship program and development of a new integrated campus for the Agency in White Oak, Maryland. Under his leadership, the FDA experienced dramatic increases in resources enabling implementation of many new programs designed to strengthen the FDA in its mission to protect and promote public health. He has emphasized FDA’s role in working with external partners to assure quality throughout the entire life cycle of the products it regulates.
Dr. von Eschenbach joined FDA after serving for four years as Director of the National Cancer Institute (NCI) at the National Institutes of Health where he set an ambitious goal to eliminate the suffering and death due to cancer by rapid acceleration and integration of the discovery-development-delivery continuum. While at NCI, he committed resources to ensure the application to oncology of nanotechnology, genomics, proteomics, bioinformatics, and other emerging technologies. At the time of his appointment by President Bush to serve as Director of NCI, he was President-Elect of the American Cancer Society.
Andrew C. von Eschenbach, MDPresident, Samaritan Health Initiatives: Adjunct Professor at University of Texas MD Anderson Cancer Center; Commissioner U.S. Food & Drug Administration (2005-2009)Bio
Peter Fasolo, PhDExecutive Vice President, Chief Human Resources Officer, Johnson & Johnson
Peter M. Fasolo is Executive Vice President, Chief Human Resources Officer, responsible for global talent, recruiting, diversity, compensation, benefits, employee relations and all aspects of the human resources agenda for Johnson & Johnson. Peter first joined Johnson & Johnson in 2004 as Worldwide Vice President, Human Resources for Cordis Corporation. Peter has more than 25 years of global experience in healthcare, having spent 13 years with Bristol-Myers Squibb in executive level, human resource roles in the pharmaceutical, medical devices and consumer segments.
Peter Fasolo, PhDExecutive Vice President, Chief Human Resources Officer, Johnson & JohnsonBio
Steve ForbesChairman and Editor-in-Chief of Forbes Media
Steve Forbes is Chairman and Editor-in-Chief of Forbes Media, the technology driven global media and branding company.
Forbes.com has become one of the world's most influential websites, with nearly 60 million unique visitors a month.
The company's flagship publication, Forbes, is the nation's leading business magazine, with a readership of 6.2 million in the U.S.. The company's 38 local editions around the world, including Forbes Asia, together have a circulation of almost 1.2 million.
Mr. Forbes writes editorials for Forbes under the heading of "Fact and Comment." A widely respected economic prognosticator, he is the only writer to have won the highly prestigious Crystal Owl Award four times. The prize was formerly given by U.S. Steel Corporation to the financial journalist whose economic forecasts for the coming year proved most accurate.
In both 1996 and 2000, Mr. Forbes campaigned vigorously for the Republican nomination for the Presidency. Key to his platform were a flat tax, medical savings accounts, a new Social Security system for working Americans, parental choice of schools for their children, term limits and a strong national defense. Mr. Forbes continues to energetically promote this agenda.
Mr. Forbes' most recent book is Reviving America: How Repealing Obamacare, Replacing the Tax Code and Reforming the Fed will Restore Hope and Prosperity, co-authored by Elizabeth Ames (McGraw-Hill Professional).
His other books include Money: How the Destruction of the Dollar Threatens the Global Economy - and What We Can Do About It, co-authored by Elizabeth Ames (McGraw-Hill Professional); Freedom Manifesto: Why Free Markets are Moral and Big Government lsn't, co authored by Elizabeth Ames (Crown Business, August 2012); How Capitalism Will Save Us: Why Free People and Free Markets Are the Best Answer in Today's Economy, co-authored by Elizabeth Ames (Crown Business, November 2009); and Power Ambition Glory: The Stunning Parallels between Great Leaders of the Ancient World and Today ... and the lessons You Can Learn, co-authored by John Prevas (Crown Business, June 2009). He also wrote: Flat Tax Revolution: Using a Postcard to Abolish the IRS (Regnery, 2005); and A New Birth of Freedom (Regnery, 1999), a book of bold ideas for the new millennium.
In 1985, President Reagan named Mr. Forbes Chairman of the bi-partisan Board for International Broadcasting (BIB). In this position, he oversaw the operations of Radio Free Europe and Radio Liberty. Broadcasting behind the Iron Curtain, Radio Free Europe and Radio Liberty were praised by Poland's Lech Walesa as being critical to the struggle against communism. Mr. Forbes was reappointed to his post by President George H. W. Bush and served until 1993.
Mr. Forbes serves on the boards of The Ronald Reagan Presidential Foundation and the Heritage Foundation. He is on the Board of Overseers of the Memorial Sloan-Kettering Cancer Center. He previously served on the Board of Trustees of Princeton University for ten years.
Steve Forbes was born on July 18, 1947, in Morristown, New Jersey. He received a B.A. in history from Princeton in 1970.
Steve ForbesChairman and Editor-in-Chief of Forbes MediaBio
Patrick GeraghtyCEO, GuideWell and Florida Blue
As CEO of GuideWell and Florida Blue, Pat Geraghty is leading a transformation at the company from a 70+ year old traditional insurance company to a $13 billion leading health solutions company with a strong health, wellness and prevention orientation. GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.
Patrick GeraghtyCEO, GuideWell and Florida BlueBio
Yi-Hsen GianRegional President, Americas, Singapore Economic Development Board
As Regional President Americas, Yi-Hsen engages with leading American multi-national companies and high growth technology companies on their Asian strategy to grow their businesses in Asia. He leads a team of dynamic Regional Directors spread across six of?ces in North and South America covering a wide spectrum of industries. He brings extensive experience in technology, business model innovation and Asia.
Prior to his current role, Yi-Hsen concurrently served as Chief Information Of?cer and Director for the following divisions within the EDB: Industry Identi?cation and Incubation (i3), Safety & Security Industry Programme Of?ce (SSIPO) and Of?ce for Space Technology & Industry (OSTIn). During this period, Yi-Hsen championed the development of a satellite industry in Singapore and of pioneering capabilities in cybersecurity and safe city capabilities for Singapore. Yi-Hsen also served in various committees for Singapore’s Research, Innovation & Enterprise 2020 masterplan.
Yi-Hsen graduated from the University of Tokyo with a Bachelor’s of Electrical Engineering and has spent over 10 years in Japan. He is ?uent in English, Japanese, Mandarin and Malay, and is married with two young children, reads extensively and enjoys outdoor jogs.
Yi-Hsen GianRegional President, Americas, Singapore Economic Development BoardBio
Neil GrimmerFounder and CEO, Habit
Neil Grimmer is the founder and CEO of Habit, pioneering personalized nutrition through deep science and food innovation. With a diverse and creative background, Neil was a punk rock musician before moving into product design at IDEO. Now with Habit, he’s building a nutrition platform to help consumers understand the transformative power of food - from test to table.
Having always been one to play with his food, he co-founded Plum Organics, the nation’s leading organic baby food brand, to bring the best, healthy food to kids. Neil sold Plum Organics to Campbell Soup in 2013 and remains active as the chairman of the board.
Today, Neil is on a mission to change the world through food once again, this time for grown-ups. His inspiration for Habit began with his journey as a tri-athlete that hung up his running shoes for a different race - running a company. But after putting the company first and his health last, he found himself 50 pounds overweight and at risk for long-term health issues. After many genetic and blood tests, trips to specialists and nutrition analysis, the idea of Habit was born, making Neil’s health journey accessible to the average consumer. Launched in 2016, Habit is the first personalized nutrition company that is challenging the multi-billion-dollar diet industry, using science to prove that each person requires different nutrients for their own optimal wellbeing.
Neil is a proven business leader, being named Innovator of the Year by Nutrition Business Journal, an Ernst & Young Entrepreneur of the Year and re-incorporating Plum Organics as a Public Benefit Corporation. Neil is also a fellow at the Aspen Institute.
Neil GrimmerFounder and CEO, HabitBio
Sanjay Gupta, MDChief Medical Correspondent, CNN; Staff Neurosurgeon, The Emory Clinic; Associate Chief of Neurosurgery, Grady Memorial Hospital
Sanjay Gupta is a practicing neurosurgeon and the multiple Emmy® award-winning chief medical correspondent for CNN reporting on health and medical news around the world. He is also a staff neurosurgeon at Emory University School of Medicine, associate chief of neurosurgery at Grady Memorial Hospital, contributor to CBS' news magazine, "60 Minutes," and the author of three New York Timesbest-selling books.
Sanjay Gupta, MDChief Medical Correspondent, CNN; Staff Neurosurgeon, The Emory Clinic; Associate Chief of Neurosurgery, Grady Memorial HospitalBio
Matthew HarrisFounding Partner, Global Infrastructure Partners and Co-Founder and Co-Chairperson of The Bedari Foundation
Matthew Harris is a founding partner of Global Infrastructure Partners (GIP) and is based in New York. Matthew leads GIP’s global energy industry investment team including crude oil and refined product, natural gas, electricity, LNG, petrochemicals and metals and mining. He is also a member of the Executive Committee of GIP and of its Investment and Portfolio Valuation Committees. Matthew has been intimately involved in GIP’s investment, management and strategic activities since its formation in 2006. He is a member of the Board of Directors of Hess Infrastructure Partners (HIP).
GIP is an independent infrastructure fund manager that combines deep industry expertise and relationships with industrial best practice operational management. GIP was founded in 2006 to invest in high quality infrastructure assets in the energy, transportation and water / waste sectors, each an area in which GIP has a depth of experience and longstanding relationships. GIP manages approximately $40 billion for its investors. Additionally, the companies in GIP’s investment portfolio have combined annual revenues greater than $32.5 billion and employ approximately 48,000 people.
Prior to the formation of GIP in 2006, Matthew was a Managing Director in the Investment Banking Department at Credit Suisse. Most recently, he was Co-Head of the Global Energy Group and Head of the EMEA Emerging Markets Group. Prior to this, Matthew was a senior member of the Mergers and Acquisitions Group and served as Co-Head of Americas Mergers and Acquisitions. Previously, he was a senior member of the Mergers and Acquisitions Group at Kidder Peabody & Co. Incorporated.
Matthew is the Co-Founder and Co-Chairperson of The Bedari Foundation. The Bedari Foundation is a private family foundation dedicated to using its experience and resources to enable significant cultural shifts in the fields of mental health and wellness, community displacement and environmental conservation. The Foundation’s vision is that humanity can cultivate the deeper sense of self-awareness and spirituality required to reassess underlying attitudes, beliefs and responsibilities about ourselves, our communities and our planet. The Bedari Foundation strives to instill the awareness necessary to help solve mental health issues such as addiction, depression and trauma, community displacement issues such as refugees and displaced persons and environmental issues such as depletion of species, global warming and over-consumption. The Foundation champions and encourages a philosophy of interconnected well-being and invests in and supports programs that further these ideals through action and education.
Matthew is co-founder of The Avatar Companies. Avatar is a private partnership focused on making equity investments in the emerging fields of mental health and wellness. Avatar's companies typically offer proprietary, branded and scaleable solutions to the mental health crisis affecting our world. Avatar’s areas of focus include diagnostics, education and training, information management, treatment and support services and technology. Avatar's vision is to develop and nurture a family of companies united in their purpose to eliminate the stigma of mental illness through investment. Having overcome his own struggles with addiction, Matthew believes investment in leading mental health and wellness businesses creates the opportunity to bring about the profound change many of us are seeking in the world today.
Matthew holds a B.A. in Political Science (cum laude) from the University of California at Los Angeles. He is a member of the Board of Directors of the
World Wildlife Fund.
Matthew HarrisFounding Partner, Global Infrastructure Partners and Co-Founder and Co-Chairperson of The Bedari FoundationBio
Shannon HartleyChief Marketing Officer, Shatterproof
Shannon Hartley is Shatterproof’s Chief Marketing Officer. She leads the teams responsible for delivering the programs and services that support the Shatterproof mission. Her team leads the marketing and educational programs to end the stigma associated with addiction, provides resources to support families and communities focused on preventing addiction and supporting those seeking information on evidence-based treatment and recovery support. Her team leads the program, fundraising and volunteerism activities for Shatterproof. She has more than 20 years of marketing and strategy experience. She began her career at Procter & Gamble in customer insights and sales roles. She led neuroscience/mental health customer insight and global strategy at Bristol-Myers Squibb. Most recently, Shannon was the Managing Director of Razorfish Health, a customer engagement agency that is part of Publicis Healthcare, the largest healthcare marketing and communications network in the world. She is a graduate of Miami University and lives in Princeton, NJ.
Shannon HartleyChief Marketing Officer, ShatterproofBio
Mark Hyman, MDPritzker Foundation Chair in Functional Medicine, Cleveland Clinic, and the Director of the Cleveland Clinic Center for Functional Medicine; Founder and Director of The UltraWellness Center; Chairman of the Board of the Institute for Functional Medicine
Dr. Hyman believes that everyone deserves a life of vitality and has the potential to create it for themselves. As an educator and practicing physician, he focuses on tackling root causes of chronic disease through Functional Medicine and transforming healthcare. In addition to his work at Cleveland Clinic, he is founder of The UltraWellness Center and Chair of The Institute for Functional Medicine.
Mark Hyman, MDPritzker Foundation Chair in Functional Medicine, Cleveland Clinic, and the Director of the Cleveland Clinic Center for Functional Medicine; Founder and Director of The UltraWellness Center; Chairman of the Board of the Institute for Functional MedicineBio
Thomas R. lnsel, MDCo-Founder and President of Mindstrong Health; Director, National Institute of Mental Health (NIMH) (2002-2015)
Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.
Thomas R. lnsel, MDCo-Founder and President of Mindstrong Health; Director, National Institute of Mental Health (NIMH) (2002-2015)Bio
Wayne Jonas, MDExecutive Director, Samueli Integrative Health Programs
Wayne B. Jonas, M.D. is a practicing family physician, an expert in integrative health and health care delivery, and a widely published scientific investigator. Dr. Jonas is the Executive Director of Samueli Integrative Health Programs, an effort supported by Henry and Susan Samueli to increase awareness and access to integrative health. Additionally, Dr. Jonas is a retired Lieutenant Colonel in the Medical Corps of the United States Army. From 2001-2016, he was President and Chief Executive Officer of the Samueli Institute, a non-profit medical research organization supporting the scientific investigation of healing processes in the areas of stress, pain and resilience.
Dr. Jonas was the Director of the Office of Alternative Medicine at the National Institutes of Health (NIH) from 1995-1999, and prior to that served as the Director of the Medical Research Fellowship at the Walter Reed Army Institute of Research. He is a Fellow of the American Academy of Family Physicians.
Wayne Jonas, MDExecutive Director, Samueli Integrative Health ProgramsBio
John J.P. Kastelein, MD, PhDProfessor of Medicine, Department of Vascular Medicine, Academic Medical Center of the University of Amsterdam and Strategic Chair of Genetics of Cardiovascular Disease
John J.P. Kastelein (1954) is Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, where he holds the Strategic Chair of Genetics of Cardiovascular Disease. Professor Kastelein has published over 850 research papers in peer reviewed journals, including Nature Genetics, Lancet, New England Journal of Medicine, JAMA and Circulation and has a Hirsch index of 102 in March 2017. His citations reached 6100 over 2016 and he is listed among the 3000 Highly Cited Researchers 2014; Dr. Kastelein is on the 10th position for the Netherlands and on the 2nd position for the Unviversity of Amsterdam. He received his medical degree in Amsterdam in 1980 where he subsequently received specialty training in internal medicine. Then, between 1986 and 1988, he was trained in medical genetics, lipidology and molecular biology at the University of British Columbia, Vancouver under the guidance of Prof. Dr. M.R. Hayden.
In 1997 and 1998 he served a visiting Professorship at the Center for Molecular Medicine and Therapeutics at the University of British Columbia, Vancouver, Canada. Upon his return to the Netherlands, he was awarded a doctorate (Cum
Laude) and in 1989 he founded the Lipid Research Clinic at the Academic Medical Center, AMC) in Amsterdam, which is currently serving as a tertiary referral centre and has become part of the department of Vascular Medicine.
The most important concept in Dr. Kastelein’s research career, developed initially at the University of British Columbia, by his mentor Dr. Hayden, and subsequently transformed into practice at the AMC in Amsterdam, the Netherlands, is the “extreme genetics” approach. This approach teaches that the study of rare human disorders that are associated with premature coronary disease have broader relevance for the understanding of the etiology of heart disease in general and will yield therapeutic targets that are valid for all patients.
This approach has been very successful, in so far that Familial Hypercholesterolemia is now internationally recognized as the paradigm for the relationship between LDL-C and heart 3 disease, a relationship substantiated by at least 50 peer reviewed manuscripts and 10 postdoctoral theses in Dr. Kastelein’s curriculum vitae.
John J.P. Kastelein, MD, PhDProfessor of Medicine, Department of Vascular Medicine, Academic Medical Center of the University of Amsterdam and Strategic Chair of Genetics of Cardiovascular DiseaseBio
David Kessler, MDProfessor of Pediatrics, Epidemiology and Biostatistics, UCSF; Commissioner, U.S. Food & Drug Administration (1990-1997)
Dr. Kessler served as Commissioner of the U.S. Food and Drug Administration under presidents George H. W. Bush and Bill Clinton. He is the author of A Question of Intent and The End of Overeating and Capture: Unraveling the Mystery of Mental Suffering, both New York Times bestsellers. Dr. Kessler is a pediatrician and has been the Dean of the medical schools at Yale and the University of California, San Francisco (UCSF). He is currently a professor of pediatrics and epidemiology and biostatistics at UCSF. Dr. Kessler is a graduate of Amherst College, the University of Chicago Law School, and Harvard Medical School.
David Kessler, MDProfessor of Pediatrics, Epidemiology and Biostatistics, UCSF; Commissioner, U.S. Food & Drug Administration (1990-1997)Bio
Mehmood Khan, MDVice Chairman and Chief Scientific Officer, PepsiCo
Mehmood Khan oversees PepsiCo’s global sustainability initiatives and leads PepsiCo’s Global R&D efforts. Prior to joining PepsiCo he was president of Global R&D, for Takeda, Japan’s largest pharmaceutical company. Previously, he was a practicing physician and faculty member at the Mayo Clinic, Hennepin County Medical Center and the University of Minnesota, leading programs in diabetes, endocrinology, metabolism and nutrition.
Mehmood Khan, MDVice Chairman and Chief Scientific Officer, PepsiCoBio
Mark KingPresident, adidas North America
As president of adidas North America, Mark King oversees the business in the U.S. and Canada and is responsible for driving the vision and culture. Mark began his current role in June 2014. Mark is a turnaround expert and has a long and successful track record with the company. He was with TaylorMade for 34 years, beginning his career in the early 1980s as territory sales representative. adidas acquired TaylorMade in 1997 and Mark was elevated to president in 1999 and then CEO in 2002. Under Mark’s leadership from 1999 to 2013, TaylorMade became the leading and most profitable golf company in the world, with sales increasing from $300 million to $1.7 billion.
Mark KingPresident, adidas North AmericaBio
David KirkpatrickFounder, Host, and CEO of Techonomy
Founder, host, and CEO of Techonomy, David Kirkpatrick is a journalist, commentator about technology, and author of the bestselling book “The Facebook Effect: The Inside Story of the Company that is Connecting the World,” published in 32 countries. He spent 25 years at Fortune, and founded and hosted its Brainstorm and Brainstorm Tech conferences. In addition to writing for Techonomy, he contributes to Forbes and Vanity Fair. He is a member of the Council on Foreign Relations
David KirkpatrickFounder, Host, and CEO of TechonomyBio
Robert Knight, PhDFounding Director, Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego
Rob Knight is the founding Director of the Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego. Before that, he was Professor of Chemistry & Biochemistry and Computer Science in the BioFrontiers Institute of the University of Colorado at Boulder, and an HHMI Early Career Scientist. He is a Fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology. He received the 2017 Massry Prize for his microbiome research. In 2015 he received the Vilceck Prize in Creative Promise for the Life Sciences.
Robert Knight, PhDFounding Director, Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San DiegoBio
Daniel Kraft, MDFaculty Chair for Medicine, Singularity Univ., Founder & Chair, Exponential Medicine
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as Faculty Chair for Medicine & Neuroscience at Singularity University since SU's inception, and founded and is chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford. He has multiple patents on medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California, San Francisco.
Daniel was selected as a fellow of the inaugural 2016 class of the Aspen Institute Health Innovators Fellowship and is a member of the Aspen Global Leadership Network.
Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. Clinical work focuses on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. He also implemented the first text-paging system at Stanford Hospital. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data driven, and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies. Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
Daniel Kraft, MDFaculty Chair for Medicine, Singularity Univ., Founder & Chair, Exponential MedicineBio
Howard Krein, MD, PhDChief Medical Officer, StartUp Health; Senior Director of Health Policy & Innovation at the Sidney Kimmel Cancer Center; Associate Professor of Facial Plastics and Reconstructive Surgery Microvascular Surgery, Dept. of Otolaryngology/ Head and Surgery, Thomas Jefferson University
Dr. Howard Krein is Chief Medical Officer at StartUp Health, which is organizing and supporting an army of Health Transformers. Dr. Krein acts as a strategic clinical advisor to the world’s largest portfolio of digital health companies and responsible for shaping StartUp Health’s moonshot themes to help improve the health of everyone in the world.
Dr. Krein currently serves as Senior Director of Health Policy & Innovation at the Sidney Kimmel Cancer Center. He also currently serves as the Assistant Professor of Otolaryngology: Head & Neck Surgery at Thomas Jefferson University and a founding partner and co-director of Jefferson’s Facial Aesthetic and Reconstructive Center.
Dr. Krein is part of an exclusive group of physicians with two doctorates, receiving his M.D. from Thomas Jefferson Medical College in Philadelphia and a Ph.D. in Cell and Developmental Biology from UMDNJ/Robert Wood Johnson Medical School. Dr. Krein completed internships in both Emergency Medicine and General Surgery, a residency in Otolaryngology: Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia and a Fellowship in Facial Plastic and Reconstructive Surgery at Medical College of Virginia in Richmond Virginia. He earned his Bachelor’s degree in Biology and a Master’s degree in Neuroscience from Rutgers University. Dr. Krein lives in Philadelphia, PA.
Howard Krein, MD, PhDChief Medical Officer, StartUp Health; Senior Director of Health Policy & Innovation at the Sidney Kimmel Cancer Center; Associate Professor of Facial Plastics and Reconstructive Surgery Microvascular Surgery, Dept. of Otolaryngology/ Head and Surgery, Thomas Jefferson UniversityBio
Richard E. Lapchick, PhDChair of DeVos Sport Business Management Program and President, The Institute for Sport and Social Justice
Human rights activist, pioneer for racial equality, internationally recognized expert on sports and social issues, scholar and author Richard E. Lapchick is often described as “the racial conscience of sport.” He brought his commitment to equality and his belief that sport can be an effective instrument of positive social change to University of Central Florida where he accepted an endowed chair in August 2001 to launch the DeVos Sports Business Management Program. It has been named one of the nation’s top five programs by the Wall Street Journal, the New York Times and ESPN The Magazine. In 2009 it was named the #1 MBA program in the nation for volunteer service. In 2015 it was named the number 2 program in the world by SportsBusiness International.
Lapchick is a prolific writer. He is working on his 17th book. Lapchick is a regular columnist for ESPN.com and The Sports Business Journal. He has written more than 550 articles and has given more than 2,800 public speeches. He has spoken in the United States Congress, at the United Nations and in the European Parliament.
Under Lapchick’s leadership, the DeVos Program launched The Institute for Diversity and Ethics in Sport (TIDES) in December 2002. TIDES publishes the critically acclaimed Racial and Gender Report Card (RGRC). Lapchick created the RGRC in the late 1980s. It is an annual study of the racial and gender hiring practices of the major professional sports, and college sport in the United States.
Lapchick helped found Northeastern University’s Center for the Study of Sport in Society in 1984 and also helped form the National Consortium for Academics and Sport (NCAS) in 1985. It is a group of over 280 colleges and universities that created the first of its kind degree completion and community service programs. To date, 31,855 athletes have returned to NCAS member schools. Over 14,985 have graduated. Nationally, the NCAS athletes have worked with nearly 19.1 million students in the school outreach and community service program, which focuses on teaching youth how to improve race relations, develop conflict resolution skills, prevent gender violence and avoid drug and alcohol abuse. They have collectively donated more than 20.8 million hours of service while member colleges have donated more than $300 million in tuition assistance. Lapchick helped create National Student-Athlete Day in 1988 which to date has recognized more than 2.6 million high school students for being citizen-scholar- student-athletes.
In December of 2006, Lapchick, his wife and daughter and a group of DeVos students formed the Hope for Stanley Alliance which organizes groups of student-athletes and sports management students to go to New Orleans to work in the reconstruction efforts in the devastated Ninth Ward. As of the summer of 2016, Hope for Stanley members have spent 49 weeks working on rebuilding more than 125 homes. Lapchick was named an honorary citizen by the New Orleans City Council in October 2007. HFS has also worked with Tornado victims in Tuscaloosa, AL in New York with the victims of Hurricane Sandy.
Considered among the nation's experts on sport and social issues, Lapchick has appeared numerous times on Good Morning America, Face The Nation, The Today Show, ABC World News, NBC Nightly News, the CBS Evening News, CNN and ESPN as well as numerous other news broadcasts.
Lapchick has received nine honorary degrees. He was named the Florida Public Citizen of the Year in 2006. He has been the recipient of numerous humanitarian awards including the Lifetime Achievement Award for Work in Civil Rights from the Rev. Jesse Jackson and the Rainbow/Push Coalition in 2009. He was inducted into the Sports Hall of Fame of the Commonwealth Nations in the category of Humanitarian along with Arthur Ashe and Nelson Mandela. Lapchick has won the Arthur Ashe Voice of Conscience Award, the Women’s Sports Foundation Presidents Award, the Ralph Bunche International Peace Award and the Wendell Scott Pioneer Award in 2004 and the NASCAR Diversity Award in 2008 for leadership in advancing people of color in the motor sports industry. He was also inducted into the Central Florida Sports Hall of Fame in 2010 and the Multi-Ethnic Hall of Fame in 2011.
In 2012, Lapchick was honored by the Holocaust Memorial Resource and Education Center of Florida at its annual Dinner of Tribute. He also received the Champions Award from the Alliance of Women’s Coaches, the only male to receive the award in 2012. The Black Coaches Association presented Lapchick with their Distinguished Service Award which was only the 2nd time they presented this award in 28 years. Lapchick received the Mannie Jackson Human Spirit Award at the 2012 Basketball Hall of Fame enshrinement ceremonies.
In August of 2013, he received the Pioneer Award from the National Association of Black Journalists. In 2014, the National Basketball Retired Players Association gave Lapchick, Bill Russell and Pat Summit their Life Achievement Award. Lapchick was inducted into the New York City Basketball Hall of Fame in 2015. He was named as one of Beyond Sports Inspirational 50 people (living and passed) who used sport to change the world along with Billie Jean King, Muhammad Ali, Nelson Mandela and David Stern.
In 2016, he was honored by the Harvard Medical School with the Harvard Impact Global Health Catalyst Distinguished Leader Award for his work in diversity and inclusion.
Shut-Out Trafficking is the NCAS’ effort to combat human trafficking with week-long programs on 10 NCAS campuses each year starting in 2014-15 engaging student-athletes, coaches and athletic administrators to help inform their campuses about this huge issue. It is a partnership with the US Fund for UNICEF. In its first two years it engaged for more 40,000 students, student-athletes, faculty and administrators on those campuses. SOT will be on 10 campuses in 2016-17.
He is listed in Who's Who in America, Who's Who in American Education, Who's Who in Finance and Industry, and Who's Who in American Business. Lapchick was named one of the 100 Most Powerful People in Sports for six years, one of the 20 Most Influential People in College Sport and one of the 20 Most Influential People in Sport in Florida.
Lapchick was one of 200 guests personally invited by Nelson Mandela to his inauguration after leading the American sports boycott of South Africa from 1975 until the end of Apartheid.
Lapchick is a board member of the OnePULSEFoundation, Florida Abolitionist, the Women’s Sports Foundation and the Central Florida YMCA. He is on the advisory boards of the Positive Coaching Alliance, Harbor House, ESPN-W, Champion Women, the SEED Project and the Giving Back Fund. He is a founder of the Hope for Stanley Alliance and the Shut Out Trafficking campaign.
Richard Lapchick is the son of Joe Lapchick, the famous Original Celtic center who became a legendary coach for St. John's and the Knicks. He is married to Ann Pasnak and has three children and four grandchildren.
Richard E. Lapchick, PhDChair of DeVos Sport Business Management Program and President, The Institute for Sport and Social JusticeBio
Governor Michael LeavittFounder, Leavitt Partners; Secretary of the U.S. Department of Health and Human Services (2005-2009); Administrator of the Environmental Protection Agency (2003-2005); Former Governor of Utah (1993-2003)
Mike Leavitt is the founder of Leavitt Partners where he helps clients navigate the future as they transition to new and better models of care. In previous roles, Mike served in the Cabinet of President George W. Bush (as Administrator of the Environmental Protection Agency and Secretary of Health and Human Services) and as a three-time elected governor of Utah. Mike is a seasoned diplomat, leading U.S. delegations to more than 50 countries. He has conducted negotiations on matters related to health, the environment, and trade.
Governor Michael LeavittFounder, Leavitt Partners; Secretary of the U.S. Department of Health and Human Services (2005-2009); Administrator of the Environmental Protection Agency (2003-2005); Former Governor of Utah (1993-2003)Bio
Ivan LendlFormer World Tennis No. 1 and Eight-time Grand Slam Champion
Although he'd been a prodigious winner for four years, it was not until the French final of 1984 that Ivan Lendl began to really stake his claim to greatness. Then, from two sets down to the year's leading player, John McEnroe, Lendl battled back to win in five sets, seizing the first of his eight major singles (of 19 finals). He won two other French (1986-87), two Australian (1989, '90), and three U.S. (1985, '86, '87). Until 1984, at 24, his competitive zeal in big finals had been questioned, particularly after his U.S. Open finals losses to Jimmy Connors of 1982-83. But Lendl dispelled all that, and won in 1985 over McEnroe, in 1986 over Miloslav Mecir and 1987 over Mats Wilander. Ivan's two other French titles were banged out in 1986 and 1987 over Swedes Mikael Pernfors and Wilander.
In Australia, after falling in the 1983 final to Wilander, he bounced back to win in 1989 over Mecir and 1990 over Edberg in an injury walkover. His 1985 U.S. Open conquest of McEnroe hoisted him past the New Yorker to No. 1 in the world, a position he held until losing the Open in 1988 to Wilander - 156 straight weeks, four short of Jimmy Connors's record at the time. He returned to No. 1 for 1989 and spent a total 270 weeks at the peak during 13 seasons in the Top 10 between 1980 and 1992. Lendl's Flushing Meadow time has been spectacular: Appearing in eight successive finals (from 1982), he equalled the record of Big Bill Tilden (1918-25). His loss of the 1988 final to Wilander halted a 27-match winning streak in the U.S. championship, second only to Tilden's string of 42 between 1920 and the quarters of 1926.
Born March 7, 1960, at Ostrava, Czechoslovakia, and reared there, he has an excellent tennis bloodline. His mother, Olga Lendlova, was a Top Ten player in their homeland, ranking as high as No. 2. His father, Jiri Lendl, also was a fine player, ranking as high as No. 15, and who, in 1990, became president of the Czechoslovak Tennis Federation. Unlike countrywoman Martina Navratilova, he did not announce his defection, but left no doubt when he settled in the U.S. in 1984, and declined to play further Davis Cup after 1985. In 1992, he became a U.S. citizen.
In 1980, Lendl, unbeaten in seven singles and three doubles, led Czechoslovakia to its lone Davis Cup. Before an uproarious final round crowd in Prague, he anchored the 4-1 triumph over Italy. He won both his singles on the first day and, with Tomas Smid, clinched with a stirring doubles decision over Adriano Panatta and Paolo Bertolucci.
A 6-foot-2, 175-pound, right-handed paragon of hard work and fitness, he amassed stunning numbers campaigning tirelessly between 1980 and 1983, when he won 36 of 101 tournaments. He played 32 in 1980, winning three on a 113-29 match record, and won 15 of 23 in 1982 on 107-9. He won 11 of 17 in 1985 on 84-7. His last big production year was 1989: 10 of 17 on 79-7. His 92nd pro singles title in 1992 left him second only to Connors' 109 in the open era. In 1982 he put together the third longest winning streak of the open era, 44 straight matches, two shy of Guillermo Vilas' 1977 record.
A basher from the baseline, relying on strength and heavy topspin, Lendl wasn't particularly stylish but got the job done with an intimidating will and appetite for victory. His anticipation and speed afoot were often overlooked. Ivan's pursuit of the one prize beyond him, Wimbledon, was Jobian. He played 14 times at the Big W but, strain and try as he did to become a serve-and-volleyer, and as close as he came - final-round losses to Boris Becker in 1986 and Pat Cash in 1987 - grass was his no-no. That may be unfair to say about a man who batted .774 there, was also thrice a semi-finalist, but he joined Ken Rosewall and Pancho Gonzalez as the greatest never to win the Big W. An aching back didn't help as, seeded seventh, he lost his last attempt, in 1993, to Arnaud Boetsch in the second round.
The damaged back caused him to default in the third set of his second-rounder against Bernd Karbacher at the 1994 U.S. Open. He would not play again, and announced his retirement shortly after that at age 34, ranked No. 30. His last title, Tokyo (indoor) in 1993, was a 6-4, 6-4 win over Todd Martin, and his last final, Sydney 1994, was a loss to Pete Sampras. Lendl's was a hefty pro career of 17 years: 94 singles titles, six doubles titles, and a 1,279-274 singles W-L record (.805), topped only by Connors. He was the all-time prize money champ with $21,282,417 when he quit. An avid golfer, he lives in Connecticut.
MAJOR TITLES (8) - Australian singles, 1989, 1990; French singles, 1984, 1986, 1987 US. singles, 1985, 1986, 1987.
OTHER U.S. TITLES - Clay Court singles, 1985; Pro singles, 1992, 1993, 1994.
DAVIS CUP - 1978, 1979, 1980, 1981, 1982, 1983, 1984, 1985; record: 18-11 in singles, 4-4 in doubles.
SINGLES RECORD IN THE MAJORS - Australian (48-10), French (53-12), Wimbledon (48-14), US. (73-13).
Ivan LendlFormer World Tennis No. 1 and Eight-time Grand Slam ChampionBio
Thom A. Mayer, MD, FACEP, FAAPMedical Director, NFL Players Association; Clinical Professor of Emergency Medicine at the George Washington University and Senior Lecturing Fellow, Duke University School of Medicine
Dr. Thom Mayer is the Medical Director of the NFL Players Association, a position he assumed at the request of Gene Upshaw on the day Korey Stringer, a tackle for the Minnesota Vikings, passed away from heat stroke. The NFLPA had never before had a Medical Director. Under the leadership of current NFLPA Executive Director DeMaurice Smith, Dr. Mayer and his team pioneered a new era in assuring that the health and safety of NFL athletes are protected. He was named one of “The Top 100 Most Important People in the NFL” by USA Today in 2016.
Thom A. Mayer, MD, FACEP, FAAPMedical Director, NFL Players Association; Clinical Professor of Emergency Medicine at the George Washington University and Senior Lecturing Fellow, Duke University School of MedicineBio
Mark McClellan, MD, PhDRobert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Margolis Center for Health Policy at Duke University; Commissioner U.S. Food & Drug Administration (2002-2004)
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He was previously Senior Fellow at the Brookings Institution and a faculty member at Stanford University.
Mark McClellan, MD, PhDRobert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Margolis Center for Health Policy at Duke University; Commissioner U.S. Food & Drug Administration (2002-2004)Bio
Robert McDonald8th Secretary, Department of Veterans Affairs (2014-2017); President and Chief Executive Officer, The Proctor & Gamble Company (2009-2013)
Robert A. McDonald was nominated by President Obama to serve as the eighth Secretary of Veterans Affairs and was confirmed by the United States Senate on July 29, 2014.
Secretary McDonald led the Department in its ambitious transformational journey to be a world-class service provider and the No. 1 customer-service agency in the Federal government giving Veterans consistent, high-quality experiences. That undertaking began with reinforcing the importance of VA’s inspiring mission to care for those “who shall have borne the battle,” their families, and their survivors, and re-emphasized VA’s commitment to its I-CARE Values of Integrity, Commitment, Advocacy, Respect, and Excellence. The Department’s MyVA transformation strategy was its catalyst for change, for modernizing VA’s culture, processes, and capabilities.
Over the course of Secretary McDonald’s tenure, VA expanded Veteran access by focusing on staffing, space, productivity, and VA Community Care. VA continued driving down the disability claims backlog while positioning the Department for sweeping appeals reform. And VA made substantial progress in bringing an effective end to Veteran homelessness.
Robert McDonald8th Secretary, Department of Veterans Affairs (2014-2017); President and Chief Executive Officer, The Proctor & Gamble Company (2009-2013)Bio
Ashley McEvoyCompany Group Chairman, Consumer Medical Devices, Johnson & Johnson
Ashley McEvoy is Company Group Chairman for Johnson & Johnson Vision and Johnson & Johnson Diabetes Care Companies, and a member of the Management Committee. In her role, she leads two medically directed, consumer-informed businesses within the company’s global medical device segment. The companies, best known for their market-leading ACUVUE® Brand Contact lenses, TECNIS® Family of Intraocular Lenses and ONETOUCH® Diabetes Devices, post annual sales of nearly $6 billion and are fully-integrated operating companies encompassing strategy, innovation, prototyping, clinical trials, sales, marketing, manufacturing, distribution, and business development and, employ more than 12,000 associates around the world.
Ashley’s varied career that spans more than 20 years at J&J has given her a combination of health care, medical device and brand building savvy that make her particularly suited to size up and respond to the challenges inherent in running these hybrid businesses. In four years under Ashley’s leadership, the contact lens platform added $1B in cume sales, an increase of 11% and returned to above-market performance. The Diabetes Care team outperformed competitive composites in 2015 and is growing market share.
Ashley has run four multibillion dollar companies and given birth to five healthy children, demonstrating that you can have a full personal life while rocketing to the top of a Fortune 50 company. As Worldwide President, Ethicon, Inc., she brought dynamic energy to a 100-year-old, $2.5 billion surgical suture business, accelerating sales and doubling net income in 3 years. She also strengthened the company’s capabilities, improving the five-year value of the Company’s new product pipeline by 26 percent. Earlier, Ashley served as President of McNeil Consumer Healthcare where she transformed the company by overseeing the acquisition and integration of Pfizer Consumer Healthcare (the largest acquisition in the history of Johnson & Johnson at that time). During her tenure, McNeil delivered record double-digit sales and income growth, and held leading market share in every product category in which they competed.
Ashley is committed to diversity and inclusion and she has assembled high performing teams, changing the composition of her own leadership team from 10% diverse to 50% diverse. She serves as the executive sponsor of the Open & Out employee resource group which supports the LGBT community globally. Under her leadership, this group has advanced Johnson & Johnson’s goal having its workforce reflect the populations it serves, and created educational materials to improve understanding and create safe, inclusive work environments, and earning accolades from multiple external organizations.
Ashley’s accomplishments have been recognized by numerous business and philanthropic organizations and she was named a “2012 Working Mother of the Year” by Working Mother Magazine. She is an active member of her community, serving as a board member for the CEO Council for Growth, an organization focused on economic growth for the tri-state region and very involved in Pennsylvania Chamber of Commerce activities.
Ashley McEvoyCompany Group Chairman, Consumer Medical Devices, Johnson & JohnsonBio
Anil MenonGlobal President, Smart+Connected Communities, Cisco
Cisco is now ranked globally as the top technology leader in smart cities and community digital transformation.
As global president of the Cisco Smart+Connected Communities business, Anil Menon drives success by setting the vision and strategy for its Cisco Kinetic for Cities solutions portfolio, for its partner relationships and its investment policies.
Anil has shepherded the Cisco Smart+Connected Communities initiative from a startup within Cisco to a billion dollar business. Anil's career has been forged at the intersection of business innovation and market disruption. Prior to joining Cisco, Anil was corporate vice president of strategy at IBM, where he held several global functional roles ranging from chief marketing and strategy officer for IBM's global hardware business. Anil managed IBM's corporate transition from a hardware brand to a business technology brand and served on IBM's Strategy Team that helped the company’s CEO set overall business and investment strategy.
Prior to being recruited by IBM in 2001, Anil was a successful tenured professor with an extensive international consulting practice with global blue chip companies. He holds two PhDs—in marketing strategy and statistics—and was on the graduate faculty at Emory University's Goizueta Business School in Atlanta, Georgia. His doctoral dissertation was funded by GE and Harvard Business School’s international business think tank, Strategic Planning Council, where Anil later served on the executive council. Sony Corporation also appointed Anil a Sony Business Fellow during the mid-90s.
Anil is active with the World Economic Forum where he co-chaired its Global Agenda Council on the Future of Cities and also participates in its Future of Health global agenda council. He serves on the board of directors for the Center for Customer Insights at the Yale University School of Management and is on the advisory board for the Johns Hopkins University Carey Business School.
Anil resides in Orlando, Fl., but travels extensively worldwide. Anil is married and the proud father of two daughters. He collects 19th century Baluchi carpets and the earliest (1890-1910) Edison cylinder phonographs.
Anil MenonGlobal President, Smart+Connected Communities, CiscoBio
Robert S. MerkelGeneral Manager, IBM Healthcare and Life Sciences
Rob Merkel is a general manager within IBM Healthcare and Life Sciences. He has supported the launch and transformation of IBM businesses, pioneered new offerings and served as a transformational change agent delivering profitable growth across complex portfolios globally.
Rob was a founding executive of both the Watson Group and Watson Health holding multiple leadership positions throughout its rapid evolution. In Watson Group, Rob pioneered the application of cognitive technologies within healthcare and supported the strategy and launch of Watson Health. Within Watson Health, Rob was the General Manager of Oncology and led the development and commercialization of oncology offerings leveraging artificial intelligence technologies. Within a two-year period, three clinical offerings were introduced commercially and deployed in more than 155 hospitals across 4 continents. Prior to Watson, Rob was the Global Industry Leader for Healthcare and Life Sciences within IBM Global Business Services. While in this role, Rob led a team of over 6,000 professionals globally with annual revenue exceeding $1.2 Billion.
Rob is a frequent speaker at industry events, author of publications and has been frequently quoted in TV, radio and print media. In 2015 he was named as one of the "Top 40 Healthcare Transformers" by Medical Marketing & Media. He earned his bachelor of science in industrial engineering from Lehigh University and masters of business administration from Columbia Business School. He resides in New Jersey with his wife and two children.
Robert S. MerkelGeneral Manager, IBM Healthcare and Life SciencesBio
Edmundo Muniz, MDChief Executive Officer, Certara
Dr. Muniz has led Certara as CEO since 2014. During his twenty-five-year scientific and business management career, he has held multiple senior executive roles in the pharmaceutical industry and public health organizations.
Among these roles, Dr. Muniz served as Head of Worldwide Pharmacovigilance and Epidemiology, Cardiovascular Business Unit Leader, and Vice President of Oncology Clinical Development at Eli Lilly and Company.
Dr. Muniz earned an MD degree from the Autonomous University of Santo Domingo in the Dominican Republic and a PhD in Population Planning and International Health from the University of Michigan. He is also a graduate of the Epidemic Intelligence Service Program and the Preventive Medicine and Public Health Fellowship at the Centers for Disease Control and Prevention (CDC).
In 2015 Dr. Muniz was named as one of the PharmaVOICE 100 most inspirational “Commanders in Chief” leaders in the life-sciences industry.
Edmundo Muniz, MDChief Executive Officer, CertaraBio
Leena NasserExecutive Director, The Chopra Institute
Leena Nasser specializes in the intersection of neuroscience, cognitive psychology and education. She is the Executive Director of The Chopra Institute, a leading global non-profit startup aiming to build the next wave of preventative health care. Leena is catalyzing a new movement aimed at bringing about a holistic, systemic and innovative approach to the prevention of noncommunicable disease which by 2020 will be responsible for 73% of deaths worldwide.
Leena NasserExecutive Director, The Chopra InstituteBio
Sir David Nicholson KCB CBEFormer Chief Executive of the National Health Service in England Chair, Universal Health Coverage Forum, World Innovation Summit for Health
Sir David Nicholson KCB CBE provides advice and guidance to both governments and individual organisations interested in improving health and healthcare, enabling progress towards universal healthcare coverage. He has worked in China, Brazil, the USA, Europe and the Middle East, independently, and in association with the World Health Organisation, and World Bank. Sir David is Chair of the Universal Health Coverage Forum of the World Innovation Summit for Health. In addition, he is adjunct Professor of Global Health at the Institute of Global Health Imperial College, Senior Health Advisor at Abraaj Group as well as Abraaj Chair of the Impact Committee for the Abraaj Global Health Fund and Advisor to the British Association of Physicians of Indian Origin and Lancet Commissioner to Global Surgery.
Previously, Sir David had been the Chief Executive of the National Health Service in England for 8 years. The NHS is recognised as one of the largest and most successful integrated healthcare systems in the world. Prior to that he held many senior positions in the NHS, running hospitals and healthcare systems in major cities including London and Birmingham.
Sir David’s contribution to healthcare was recognised by the ward of the CBE in 2008, and he was knighted by Her majesty the Queen in 2010.
Sir David Nicholson KCB CBEFormer Chief Executive of the National Health Service in England Chair, Universal Health Coverage Forum, World Innovation Summit for HealthBio
Carlos M. Nunez, MDChief Medical Officer, ResMed
As Chief Medical Officer for ResMed, Dr. Nunez leads Medical Affairs, Market Access, Healthcare Economics, Government Affairs and Clinical Science and Innovation for the world's leading provider of solutions for sleep and respiratory care. This global, multidisciplinary team provides the professional and scientific expertise to align the clinical, economic and public policy realities of modern healthcare with the patient-centered mission and business strategy of ResMed. This includes the safety, quality and regulatory efforts that touch every phase of the patient experience and product lifecycle, as well as the evidence generation and early-stage technology development that defines the cutting edge of clinical research, medical science, and advanced data analytics in sleep and respiratory care.
Carlos joined ResMed from Becton, Dickinson and Company (BD) where he was Senior Vice President of Medical Affairs, and led the office of Science, Medicine and Technology for BD’s largest division. Prior to that, Carlos was Chief Medical Officer at CareFusion, where he built and led a global team that provided medical oversight for all of the businesses and functions of the company. From 2000 to 2011 he was the Chief Physician Executive at Picis, Inc., an industry-leading medical informatics company, which became part of the Optum division of UnitedHealth Group. At Picis/Optum Carlos provided medical leadership as well as clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.
Carlos received his Medical Doctor (M.D.) degree from the University of Miami School of Medicine; where he also completed his postgraduate training in anesthesiology, critical care medicine and clinical research. Before beginning his career in the MedTech industry, Carlos was a practicing anesthesiologist, intensivist and hospitalist, director of critical care research, informatics and analytics, and the Duke University educational affiliation at Carolinas Medical Center Northeast.
Carlos M. Nunez, MDChief Medical Officer, ResMedBio
Peder Olofsson, MD, PhDDirector, The Center for Bioelectronic Medicine at the Department of Medicine, Solna Karolinska Institutet
Peder Olofsson leads the Experimental Cardiovascular Medicine group and directs the Center for Bioelectronic Medicine at the Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Olofsson also holds a position as Associate Investigator at the Feinstein Institute for Medical Research, Manhasset, New York, U.S.A. His research focuses on the molecular mechanisms of reflex control of inflammation. The research ultimately aims to make it possible to treat inflammatory disease by targeting specific neural circuits using electrical interfaces.
Peder Olofsson, MD, PhDDirector, The Center for Bioelectronic Medicine at the Department of Medicine, Solna Karolinska InstitutetBio
Clark C. Otley, MDMedical Director, Department of Business Development, Mayo Clinic
Clark C. Otley, MD serves as the Medical Director of the Department of Business Development at Mayo Clinic, which includes the Divisions of Mayo Clinic Ventures and Corporate Business Development. In this capacity, he is responsible for leading technology development and commercialization of Mayo’s intellectual property and for strategic corporate business development activities at Mayo Clinic in direct partnership with Mayo Clinic’s CEO. With over 500 invention disclosures annually and revenue of $66M in 2017, Mayo Clinic Ventures commercializes Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research, and education at Mayo Clinic.
Dr. Otley is a practicing dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, Professor of Dermatology at Mayo Clinic College of Medicine and served as Chair of the Department of Dermatology from 2008-2017. He serves as Vice President of the Destination Medical Center Economic Development Agency Board, was Founding President of the International Transplant Skin Cancer Collaborative, is Vice President of the American Board of Dermatology, and his technology was the basis of a start-up company focused on minimally invasive varicose vein treatment.
Clark C. Otley, MDMedical Director, Department of Business Development, Mayo ClinicBio
Paul OwenChief Executive Officer, OneOme
Paul Owen is the chief executive officer at OneOme. OneOme, named by Fast Company as one of the World’s Most Innovative Companies in 2018, is a healthcare technology company that provides pharmacogenomic solutions that help providers prescribe and manage more effective medications using a patient’s genetic information and predicted medication response. Prior to OneOme, Paul led the global commercialization team at Invitae, a hereditary disease diagnostics company that completed their IPO while he was there. Prior to Invitae, Paul served as vice chair of global business development at Mayo Clinic. During his time at Mayo, he was also the leader of Mayo Medical Laboratories’ global commercial team, one of the world’s largest full service reference labs. Paul has held previous leadership roles at Zimmer and Boston Scientific. He received his B.S. in business administration from the University of Wisconsin – Stout.
Paul OwenChief Executive Officer, OneOmeBio
Mehmet Oz, MD, FACSProfessor of Surgery at Columbia University and nine-time Daytime Emmy® Award winner for The Dr. Oz Show
Dr. Oz has won nine Daytime Emmy® Awards for “The Dr. Oz Show” and is Professor of Surgery at Columbia University. His research interests include heart replacement surgery, minimally invasive surgery, alternative medicine and health care policy. He has authored over 400 original publications, book chapters, and eight New York Times Best Selling books, has received numerous patents, and still participates in heart surgery. He also has a newspaper column in 175 markets internationally, and has a bookazine “The Good Life”, which was voted the hottest new publication in 2014 and entered the top ten of all newsstand sales in 2015. He received his undergraduate degree from Harvard University (1982) and obtained a joint MD and MBA (1986) from the University of Pennsylvania School of Medicine and Wharton Business School. He resides in metropolitan New York City area with his wife Lisa and 4 children.
Mehmet Oz, MD, FACSProfessor of Surgery at Columbia University and nine-time Daytime Emmy® Award winner for The Dr. Oz ShowBio
Sandi PetersonGroup Worldwide Chair, Johnson & Johnson
Sandi leads over two thirds of Johnson & Johnson’s workforce, including the company’s global operating infrastructure, multiple consumer-facing businesses, and key enterprise initiatives designed to spur innovation and accelerate growth. Sandi is at the forefront of Johnson & Johnson’s efforts to transform healthcare using technology and design-thinking to leverage the company’s unique assets in innovative ways to create breakthrough solutions for patients, consumers and providers.
Sandi PetersonGroup Worldwide Chair, Johnson & JohnsonBio
Jonathan Perlin, MD, PhD, MSHA, MACP, FACMIPresident, Clinical Services and Chief Medical Officer of Nashville, Tennessee-based HCA Healthcare
Dr. Jonathan B. Perlin is President, Clinical Services and Chief Medical Officer of Nashville, Tennessee-based HCA Healthcare. He provides leadership for clinical services and improving performance at HCA’s 171 hospitals and more than 1,000 outpatient surgical, urgent care and other practice units. Current activities include: advancing electronic health records for learning healthcare and continuous improvement; driving value through (big) data science and advanced analytics; and elevating measured clinical performance and patient safety to benchmark levels. His team recently completed the landmark REDUCE MRSA study that demonstrated a 44 percent improvement on known best practices for reducing bloodstream infections.
Jonathan Perlin, MD, PhD, MSHA, MACP, FACMIPresident, Clinical Services and Chief Medical Officer of Nashville, Tennessee-based HCA HealthcareBio
Linda RosenbergPresident & CEO, National Council for Behavioral Health
Linda Rosenberg is a national expert in the financing and delivery of mental health and substance services. Under her leadership, the National Council for Behavioral Health has become our nation’s most effective advocate for behavioral health prevention, early intervention, science-based treatment, and recovery.
Harnessing the voices of the 10 million adults, children, and families served by the National Council’s 2,900 member organizations, Rosenberg helped secure passage of the federal parity law, expanded integrated behavioral and primary care services, introduced Mental Health First Aid in the U.S., and built an array of organizational, clinical and workforce improvement initiatives.
The National Council’s strong support of the Mental Health and Addiction Treatment Excellence Act will result in the first comprehensive effort to establish community accountability for the health of people with mental illnesses and addictions, the consistent utilization of evidence-based practices, and the standardized measurement of outcomes.
Rosenberg was Senior Deputy Commissioner of the New York State Office of Mental Health prior to joining the National Council. She has experience in designing and operating hospitals, community and housing programs, and implemented New York’s first Mental Health Court.
Rosenberg serves on an array of boards of directors including the Cohen’s Veteran’s Network and the Executive Committee of the National Action Alliance for Suicide Prevention.
Linda RosenbergPresident & CEO, National Council for Behavioral HealthBio
John S. Rumsfeld, MD, PhD, FACC, FAHA FESCChief Innovation Officer, American College of Cardiology and Professor of Medicine, University of Colorado School of Medicine
As Chief Innovation Officer, Dr. Rumsfeld is responsible for developing and implementing the innovation agenda for the ACC, investigating global and domestic market trends in the delivery of cardiovascular care and health information technology, and exploring new technologies and team-?based approaches to health care.
Previously, Dr. Rumsfeld served as National Director for Cardiology for the U.S. Veterans Health Administration (2012-?2017), the largest integrated health system in the U.S. Dr. Rumsfeld was also Chief Science Officer and Chairman for the ACC's National Cardiovascular Data Registry (NCDR) programs from 2005-?2016, and served on the ACC’s Board of Trustees from 2011-?2017. Dr. Rumsfeld is past-?Chair of the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Council.
A member of the American Society for Clinical Investigation (ASCI), Dr. Rumsfeld is an internationally recognized leader in cardiovascular quality of care and outcomes research, clinical registries, and healthcare analytics. In 2016, he received the Outstanding Lifetime Achievement Award for Quality of Care and Outcomes Research from the American Heart Association. He has >330 scientific publications and has presented at >120 conferences.
Dr. Rumsfeld received his medical degree from the University of Chicago and doctoral degree in Epidemiology from the University of Colorado. He completed his internal medicine internship and residency at the University of California, San Francisco, and cardiology fellowship at the University of Colorado. Dr. Rumsfeld has been an attending cardiologist at the Denver VA Medical Center since 1999.
John S. Rumsfeld, MD, PhD, FACC, FAHA FESCChief Innovation Officer, American College of Cardiology and Professor of Medicine, University of Colorado School of MedicineBio
Congressman Tim RyanUS Representative for Ohio's 13th District
Tim Ryan is a tireless advocate for working families in Ohio’s 13th District. First elected to the U.S. House of Representatives in 2002, he is currently serving in his eighth term.
Tim’s primary focus is on improving the economy and quality-of-life in Ohio. He works closely with local officials and community leaders to enhance economic competitiveness and help attract high-quality, high-paying jobs.
Tim is a dynamic leader known for challenging both parties to rebuild the middle class. He is a champion of efforts to make college more affordable, revitalize America’s cities and improve the health and well-being of American families and children. Tim’s vision for a stronger economy and his work on these and other issues has garnered national attention.
He is the author of A Mindful Nation: How a Simple Practice Can Help Us Reduce Stress, Improve Performance, and Recapture the American Spirit and The Real Food Revolution: Healthy Eating, Green Groceries, and the Return of the American Family Farm.
Congressman Ryan is a member of House Appropriations Committee that controls the expenditure of funds by the federal government.
Tim serves as co-chairman of the Congressional Addiction, Treatment, and Recovery Caucus and is a member of the Bipartisan Task Force to Combat the Heroin Epidemic. Through these partnerships, Tim has introduced, cosponsored, and championed bipartisan legislation to combat the opioid crisis.
Ryan serves as co-chairman of the Congressional Manufacturing Caucus and is a leading voice fighting to strengthen America’s manufacturing base and reform U.S. trade policies. The Caucus examines and promotes policies to help American manufacturers find trained, educated workers, to lead the world in developing new industrial technologies, to operate on a level playing field with foreign competitors, and to obtain the capital they need to thrive. Ryan is the leading advocate in the House to impose sanctions on unfair currency manipulation by foreign countries.
Before his election to Congress, Ryan served in the Ohio State Senate, as President of the Trumbull County Young Democrats and as Chairman of the Earning by Learning program in Warren, Ohio. He began his career in politics as a Congressional aide in 1995.
Ryan has a law degree from the University Of New Hampshire School Of Law (formerly the Franklin Pierce Law Center). He studied abroad as part of the Dickinson School of Law’s International Law Program. He received a BA in Political Science from Bowling Green State University in Bowling Green, Ohio.
Born July 16, 1973 in Niles, Ohio, Tim Ryan currently resides in Howland with his wife Andrea and three children.
Congressman Tim RyanUS Representative for Ohio's 13th DistrictBio
Dan Siegel, MDClinical Professor of Psychiatry, UCLA School of Medicine; Founding Co-Director, Mindful Awareness Research Center at UCLA
Dr. Siegel is a clinical professor of psychiatry at the UCLA School of Medicine and the founding co-director of the Mindful Awareness Research Center at UCLA. He is also the Executive Director of the Mindsight Institute which focuses on the development of mindsight, which teaches insight, empathy, and integration in individuals, families and communities. Dr. Siegel has published extensively for both the professional and lay audiences. His four New York Times bestsellers are: Mind: A Journey to the Heart of Being Human, Brainstorm: The Power and Purpose of the Teenage Brain, with Tina Payne Bryson, Ph.D: The Whole-Brain Child, No-Drama Discipline, and the upcoming The Yes Brain (2018).
Dan Siegel, MDClinical Professor of Psychiatry, UCLA School of Medicine; Founding Co-Director, Mindful Awareness Research Center at UCLABio
Robin L. Smith, MD, MBAChairman of the Board, Mynd Analytics, The Cura Foundation
Dr. Robin L. Smith is a global thought leader in regenerative medicine – one of the fastest growing segments of modern-day medicine. She received her MD from the Yale School of Medicine and an MBA from the Wharton School of Business. During her tenure as CEO of the NeoStem family of companies (NASDAQ: NBS now CLBS), which she led from 2006 to 2015, she pioneered the company’s innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization. Dr. Smith raised over $200 million, completing six acquisitions and one divestiture while the company won an array of industry awards and business recognition including a first-place ranking in the tri-state area (two years in a row), and eleventh place nationally, on Deloitte’s Technology Fast 500, and Frost & Sullivan’s North American Cell Therapeutics Technology Innovation Leadership Award.
In 2007, Dr. Smith founded the Stem for Life Foundation (SFLF), a nonpartisan 501(c)3 educational organization devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions, as opposed to merely treating their symptoms. In 2010, in order to bring the charity’s mission to a global audience, Dr. Smith forged a historic, first-of-its-kind partnership with the Vatican. As part of this relationship, the Vatican and SFLF collaborate to create high-profile initiatives that help catalyze interest and development of cellular therapies that could ultimately reduce human suffering on a global scale. Dr. Smith has served as Chairman of the Board and President of the Stem for Life Foundation since its inception and is expanding its mission further under the Cura brand.
Dr. Smith was appointed as Clinical Associate Professor, Department of Medicine at the Rutgers, New Jersey Medical School in 2017. She maintains a regular column on these topics for the Huffington Post and is coauthor of Cells Are the New Cure (2017) and The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life (2013). She is a winner of the 2014 Brava! Award, which recognizes top women business leaders in the Greater New York area. Dr. Smith was also a finalist for the 2014 EY Entrepreneur of the Year Award for the New York area, recognizing entrepreneurs who demonstrate excellence and success in the areas of innovation, financial performance, and personal commitment to their businesses and communities. In April 2016, Pope Francis awarded Dr. Smith Dame Commander with Star Pontifical Equestrian Order of Saint Sylvester Pope and Martyr. Dr. Smith was awarded the Lifetime Achievement in Healthcare and Science Award by The National Museum of Catholic Art & Library in May 2017.
In addition, Dr. Smith has extensive experience serving in executive and board-level capacities for various medical enterprises and health care–based entities. She currently is Chairman of the Board of Directors of MYnd Analytics (NASDAQ: MYND, formerly CNS Response), and serves on the Board of Directors of Rockwell Medical (NASDAQ: RMTI), Prolung DX, the advisory board of Hooper Holmes (OTCQX: HPHW) and is co-chairman of the Life Sci advisory board on gender diversity. She is Vice President and member of the Board of Directors of the Science and Faith STOQ Foundation in Rome and serves on Sanford Health’s International Board and the Board of Overseers at the NYU Langone Medical Center in NYC. She previously served on the Board of Trustees of the NYU Langone Medical Center and is a past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases and was on the board of directors of Signal Genetics (NASDAQ: SGNL) and BioXcel Corporation.
As a business leader, entrepreneur, doctor, and philanthropist, Dr. Smith is uniquely positioned to lead the global health care industry into the cellular future. A future where the cells of our bodies will stand as the foundation for a wide array of cures and big data assists physicians to determine the best course of treatment for individual patients.
Robin L. Smith, MD, MBAChairman of the Board, Mynd Analytics, The Cura FoundationBio
Nicole Spitzer, M.D. Candidate, Class of 2018University of Central Florida | College of Medicine
Nicole Spitzer is currently a 4th year medical student at the University of Central Florida College of Medicine and is preparing to enter ophthalmology residency at Louisiana State University in New Orleans, LA after graduation. Nicole has been actively involved in the American Association of Medical Colleges Organization of Student Representatives as a representative for the UCF College of Medicine for the last four years. Nicole has served as the Delegate for Medical Education for the Southern region where she shared and learned about curricular innovation across different medical schools in the United States. Nicole is passionate about global health advocacy and mission work, medical student wellness, and curricular innovation.
Nicole Spitzer, M.D. Candidate, Class of 2018University of Central Florida | College of MedicineBio
Rasesh ThakkarSenior Managing Director, Tavistock Group
Mr. Rasesh “Sesh” Thakkar serves as Senior Managing Director of Tavistock Group and has been with the Group for 25+ years. Mr. Thakkar’s areas of experience ranges across industries such as life sciences, financial services, real estate, and leisure services as well as corporate finance and structures, mergers and acquisitions, strategic planning and operations. He’s also known for being one of the visionaries behind Lake Nona.
Mr. Thakkar serves as a Director of the Orlando Economic Partnership, the Central Florida Partnership, the University of Florida Cancer Center at Orlando Health, and The Florida Council of 100.
Rasesh ThakkarSenior Managing Director, Tavistock GroupBio
Daryl TolSenior Executive Vice President. Adventist Health System; President/CEO, Florida Hospital & Central Florida Division
Daryl Tol is senior executive vice president for Adventist Health System and president/CEO for Florida Hospital, as well as the Central Florida Division. In this role, he provides executive leadership and oversight of the 16-campus division, which includes the South Region, where flagship Florida Hospital Orlando resides, and the North Region. He previously served as president/CEO for Florida Hospital and Adventist Health System's Central Florida Region. Prior to that, he served as CEO for Florida Hospital Memorial Medical Center and the five Florida Hospitals within Volusia and Flagler counties. Tol earned a master's degree in health administration from Loma Linda University, and a bachelor's degree in business administration from Walla Walla University.
Daryl TolSenior Executive Vice President. Adventist Health System; President/CEO, Florida Hospital & Central Florida DivisionBio
Anddria Clack-Rogers VarnadoVice President & Head of Strategy and Business Development for Williams-Sonoma, Inc.
As Vice President and Head of Strategy & Business Development at Williams-Sonoma, Inc., Anddria Clack-Rogers Varnado is a catalyst for developing innovative opportunities to enhance the quality of lives, starting at home. In this role, Anddria oversees M&A, new business development, competitor research and industry insights, and cross-brand initiatives across Williams-Sonoma's iconic portfolio of brands. Since joining WSI, Anddria has led the company’s acquisition of Outward, Inc., an innovative 3-D imaging company at the intersection of retail and technology, and launched WSI’s newest brand Robin, a branded collection of products focused on sleep and wellness.
Anddria leverages several years of previous expertise across management consulting, investment banking and product strategy to bring the full power of Williams-Sonoma’s products and services to customers in a unique and meaningful way. Her career accomplishments include driving breakthrough global customer insights for a leading online marketplace, leading integrated business planning for new service lines, and launching an online lifestyle and retail company. Anddria received a Master of Business Administration degree from Harvard Business School and a Bachelor of Arts degree from Clark Atlanta University, and currently resides in the San Francisco Bay Area.
Anddria Clack-Rogers VarnadoVice President & Head of Strategy and Business Development for Williams-Sonoma, Inc.Bio
Mark VerstegenPresident, Founder & Chief Executive Officer, EXOS
Mark Verstegen is recognized as one of the world’s most innovative human performance experts. Verstegen pioneered the concept of integrated performance training and has brought that system to the world’s top athletes, teams, and sports organizations; the United States military; and leading companies, such as Intel, Walgreens, LinkedIn, and Sheraton Hotels and Resorts. As the founder and president of EXOS, formerly Athletes’ Performance and Core Performance, Verstegen leads more than five hundred employees at the company’s performance centers in Arizona, California, Florida, and Texas, as well as supplying international support to top athletes and organizations.
Verstegen and EXOS consult for high-performance companies including adidas, SKLZ, Keiser, and Axon Sports, helping them with product and program inspiration, development, and testing, as well as consumer marketing. EXOS also has partnered with Mayo Clinic to advance proactive health and human performance. Verstegen serves as the director of performance for the NFL Players Association, where he focuses on player safety and welfare. He’s regularly interviewed for training insight for publications and is a sought-after industry speaker who regularly presents at the leading conferences in the field.
Verstegen is the author of six books, including "Every Day Is Game Day" (2014) and "Core Performance," which popularized integrated performance training and has sold more than two hundred thousand copies. His widely acclaimed performance system is also available online through interactive programs at www.TeamEXOS.com.
Verstegen is also a National Advisory Board Member of the Lake Nona Impact Forum.
Mark VerstegenPresident, Founder & Chief Executive Officer, EXOSBio
Nathaniel Watson, MDProfessor of Neurology, University of Washington; Director of the Harborview Medical Center Sleep Clinic and co-director of the UW Medicine Sleep Center; Former President of the American Academy of Sleep Medicine and American Board of Sleep Medicine
Nathaniel Watson, M.D., is Board Certified in sleep medicine and neurology and serves as Director of the Harborview Medical Center Sleep Clinic and co-director of the UW Medicine Sleep Center. He is the former President of the American Academy of Sleep Medicine and American Board of Sleep Medicine. Among Dr. Watson’s diverse research interests is his current focus on the genetic aspects of habitual sleep duration, sleepiness and circadian rhythms and the association between obstructive sleep apnea and cancer.
Nathaniel Watson, MDProfessor of Neurology, University of Washington; Director of the Harborview Medical Center Sleep Clinic and co-director of the UW Medicine Sleep Center; Former President of the American Academy of Sleep Medicine and American Board of Sleep MedicineBio
Michelle WilliamsDean of the Faculty, Harvard T.H. Chan School of Public Health
Michelle A. Williams, SM ’88, ScD ’91, is Dean of the Faculty, Harvard T.H. Chan School of Public Health. She is an internationally renowned epidemiologist and public health scientist, an award-winning educator, and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center.
Michelle WilliamsDean of the Faculty, Harvard T.H. Chan School of Public HealthBio
Vonda Joy Wright, MD, MSDirector, Performance and Research Initiative for Master Athletes; Founding Director, Performance and Research Initiative for Masters Athletes (PRIMA); Medical Director of the UPMC Lemieux Sports Complex
Vonda Wright is an orthopaedic surgeon and internationally recognized authority on active aging and mobility. She specializes in sports medicine and is one of only a few female orthopedic surgeons in the USA. Vonda is the founding director of the Performance and Research Initiative for Masters Athletes (PRIMA) and the Medical Director of the UPMC Lemieux Sports Complex.
Vonda Joy Wright, MD, MSDirector, Performance and Research Initiative for Master Athletes; Founding Director, Performance and Research Initiative for Masters Athletes (PRIMA); Medical Director of the UPMC Lemieux Sports ComplexBio